Advancements in clinical aspects of targeted therapy and immunotherapy in breast cancer

Breast cancer is the second leading cause of death for women worldwide. The heterogeneity of this disease presents a big challenge in its therapeutic management. However, recent advances in molecular biology and immunology enable to develop highly targeted therapies for many forms of breast cancer....

Descripción completa

Detalles Bibliográficos
Autores principales: Ye, Feng, Dewanjee, Saikat, Li, Yuehua, Jha, Niraj Kumar, Chen, Zhe-Sheng, Kumar, Ankush, Vishakha, Behl, Tapan, Jha, Saurabh Kumar, Tang, Hailin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324146/
https://www.ncbi.nlm.nih.gov/pubmed/37415164
http://dx.doi.org/10.1186/s12943-023-01805-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10324146/
https://www.ncbi.nlm.nih.gov/pubmed/37415164
http://dx.doi.org/10.1186/s12943-023-01805-y

Ejemplares similares